BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech

Biopharma Insights


AI Drug Discovery: Key Trends and …

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

July 26, 2023   by Andrii Buvailo     Business Intelligence
AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with …
Continue ›››
The Explosion of Therapeutic Modalities: Small …

The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between

July 14, 2023   by Andrii Buvailo     Articles
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
Continue ›››
The Increasing Role of CROs in …

The Increasing Role of CROs in the Pharmaceutical Industry

July 11, 2023   by Andrii Buvailo     Business Intelligence
(Last updated: July 2023) Pharmaceutical companies are increasingly outsourcing research activities to academic institutions, tech-driven companies, and private contract research …
Continue ›››
12 Notable AI-powered Biotech Companies Founded …

12 Notable AI-powered Biotech Companies Founded in 2021

June 23, 2023   by Bohdana Sokolova     Articles
Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and …
Continue ›››
How AI-Driven Multi-Omics is Reshaping Drug …

How AI-Driven Multi-Omics is Reshaping Drug Discovery

June 21, 2023   by Irina Bilous     Articles
The fusion of artificial intelligence (AI) with multi-omics - a comprehensive study encompassing genomics, transcriptomics, proteomics, metabolomics, and other related …
Continue ›››
VRG50635, a Drug Discovered Through Verge …

VRG50635, a Drug Discovered Through Verge Genomics' AI-powered planform, Shows Promising Phase 1 Results for ALS Treatment

June 20, 2023   by Irina Bilous     News
Verge Genomics, a frontrunner in the implementation of AI in drug discovery, recently concluded the Phase 1 clinical trial of …
Continue ›››
How to Discover a Preclinical Drug …

How to Discover a Preclinical Drug Candidate in Two Years

June 18, 2023   by Sabina Lee     Business Intelligence
Sponsored by Syntekabio
Recent advances in artificial intelligence (AI) has played a pivotal role in optimizing the small-molecule synthesis, standardization, scalability and CRO-based …
Continue ›››
IgGenix Advances Therapeutic Approach to Peanut …

IgGenix Advances Therapeutic Approach to Peanut Allergies with IgG4 Monoclonal Antibodies

June 16, 2023   by Irina Bilous     News
IgGenix, Inc., a California-based preclinical antibody discovery and development company, recently reported advances towards a potential therapeutic solution for peanut …
Continue ›››
Collaborative Open-Source Approaches Are the New …

Collaborative Open-Source Approaches Are the New Norm in Life Sciences Research, According to Survey

June 15, 2023   by Illia Petrov     Business Intelligence
Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and …
Continue ›››
The Rising Role of AI-enabled Digital …

The Rising Role of AI-enabled Digital Pathology in Drug Discovery

June 13, 2023   by Andrii Buvailo     Articles
The field of pathology has experienced a major shift over the past few decades. This evolution began as early as …
Continue ›››
Harnessing AI for Drug Discovery Certara …

Harnessing AI for Drug Discovery Certara Amplifies CODEX Platform Capabilities

June 11, 2023   by Irina Bilous     News
Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial …
Continue ›››
Collaboration Between Iktos and Curreio Harnesses …

Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery

June 9, 2023   by Halyna Buvailo     News
Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently …
Continue ›››
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
#advertisement
Pharma Complience Management: A UK/EU Guide

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.